logo
Lifeline BioTechnologies Signs Letter of Intent to Acquire GlobalOdds Holdings, a Premium Technology Provider in Online Gaming

Lifeline BioTechnologies Signs Letter of Intent to Acquire GlobalOdds Holdings, a Premium Technology Provider in Online Gaming

Aventura, FL May 17, 2025 --( PR.com )-- Lifeline BioTechnologies, Inc., a publicly traded company (OTC: LLBO), today announced it has signed a Letter of Intent (LOI) to acquire GlobalOdds Holdings Pty. Limited, a leading B2B online wagering technology company headquartered in Australia.
GlobalOdds is a software developer that has created a wagering platform operating under an Anjouan Gaming License, with a comprehensive suite of advanced gaming solutions for the international market. The company has developed proprietary technology and infrastructure spanning multiple gaming verticals, including sports wagering technologies, casino game integration systems, advanced customer relationship management tools, horse racing platforms, artificial intelligence-driven personalization engines, and secure payment processing frameworks. This integrated ecosystem delivers seamless gaming experiences through both business-to-business partnerships and white-label solutions, enabling operators across Europe and Asia to deploy sophisticated gaming platforms under their own brands. The company's technological innovation focuses on enhancing player engagement, optimizing retention metrics, and maximizing operator revenue through data-driven personalization and robust back-office systems.
This acquisition is LLBO's initial entry into software development for the global gaming sector and supports its transformation into a diversified online software development platform.
'The LOI with GlobalOdds marks a major milestone in our strategic roadmap,' said Greg Klok, CEO of LLBO. 'GlobalOdds has built a world-class technology stack and has strong market traction in key regions. This acquisition positions LLBO to capitalize on the growth in the global online wagering industry, projected by Horizon Research[1] to reach over $153 billion by 2030.'
Highlights of the Transaction:
GlobalOdds powers numerous enterprise-level gaming operations across multiple markets through its industry-leading platform technology, serving a diverse portfolio of B2B clients via SaaS and revenue-sharing partnerships.
The acquisition includes proprietary technology, established customer base, and strategic expansion plans into Australia and beyond.
The LOI outlines the framework for the proposed acquisition, which remains subject to customary due diligence, negotiation of definitive agreements, regulatory approvals, and other closing conditions.
Following the successful completion of this transaction LLBO intends to divest its current biotechnology business.
About Lifeline BioTechnologies, Inc. (LLBO)
LLBO is a publicly traded company focused on strategic acquisitions in high-growth digital sectors. With a renewed vision to drive innovation and shareholder value, LLBO is targeting transformative opportunities across gaming, fintech, and entertainment.
About GlobalOdds Holdings Limited
GlobalOdds is a premium provider of AI-driven gaming solutions operating in regulated international markets. With operations in Asia and Europe, GlobalOdds offers a fully integrated gaming ecosystem tailored to the evolving needs of modern gaming operators and their players.
Forward-Looking Statements
Please note that the above press release contains forward-looking statements. These statements are based on current expectations and assumptions, and may include words such as 'anticipate,' 'expect,' 'assume,' and 'predict.' Actual results may differ materially, and we assume no obligation to update these statements, except as required by law. It is important to consider potential risks and uncertainties when evaluating these forward-looking statements. Please be aware that they are not guarantees of future performance.
[1] https://www.grandviewresearch.com/horizon/outlook/online-gambling-market-size/global
Contact Information:
Lifeline Biotechnologies Inc.
Gregory Klok
786-590-5203
Contact via Email
llboinc.com
Read the full story here: Lifeline BioTechnologies Signs Letter of Intent to Acquire GlobalOdds Holdings, a Premium Technology Provider in Online Gaming
Press Release Distributed by PR.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Japanese Bonds Back on Stage With Another Sale of Longer Debt
Japanese Bonds Back on Stage With Another Sale of Longer Debt

Bloomberg

time23 minutes ago

  • Bloomberg

Japanese Bonds Back on Stage With Another Sale of Longer Debt

Japan's sovereign debt is back in the spotlight as the government prepares for another sale of super-long-term bonds after dismal showings at recent auctions, as demand for the far-end of the curve sputters across the globe. The results from the finance ministry's auction of 30-year bonds are due at 12:35 p.m. Tokyo time. The 30-year yield was at 2.945% ahead of Thursday's sale, down from 3.185% last month, the highest level since it was first sold. Some investors are concerned that yields may surge again if the 30-year bond sale sees little demand.

Hardware, Software, Meet Wetware: A Computer With 800,000 Human Neurons
Hardware, Software, Meet Wetware: A Computer With 800,000 Human Neurons

Forbes

time43 minutes ago

  • Forbes

Hardware, Software, Meet Wetware: A Computer With 800,000 Human Neurons

The Cortical Labs CL1 biological computer with human brain cells. The world's first 'code-deployable' biological computer is now for sale. The Cortical Labs CL1 costs $35,000 and has 800,000 human brain cells living and growing in a nutrient solution on a silicon chip. Computer scientists can deploy computer code directly to these neurons, which have been integrated into a 'biOS' or Biological Intelligence Operating System with what the company says is a mixture of hard silicon and soft tissue. The goal, according to the companies' founder? Smarter AI that drops some of the A and adds more of the I. Maybe, eventually, smarter brains than the ones we currently walk around with. 'The only machine or the only thing that we know of that actually has true intelligence is the brain,' founder and CEO Hon Weng Chong told me when I interviewed him five years ago, while he was still using mice neurons. 'So we said, let's start with the basic building structure, the building blocks being neurons, and let's build our way up and maybe we'll get there along the way.' Our human brains have neurons connected together in hierarchies, and from that emerges intelligence and consciousness, he adds. This approach is similar to neuromorphic computing architectures, which attempt to mimic biological brains with silicon-based hardware, but of course different in that neuromorphic chips do not typically use actual living brain cells. Cortical Labs, based in Australia, says scientists can solve today's most difficult problems with their biological computers, which they say are self-programming and infinitely flexible. A key difference between biological computers and silicon-based chips, of course, is that biological computers last even less time. The neurons that ship with your CL1 will live for 'up to six months,' at which point you'll likely have to invest in a refresh or refurbishment which provides new neurons for continued compute. And yes, biological computers need food and water and nutrients, all of which are supplied onboard via a life-support system the keeps them at optimum temperature. Plus, it filters out waste byproducts of living human cells: the kind of work kidneys might do in a full living organism. A Cortical Labs chip under a high-powered electron microscope. You can see tight connections between ... More neurons and the silicon substrate, the company says. In some ways the CL1 is more like a space ship than a computer, because it's a self-contained life support system that requires few external inputs. A key difference: the need for external power. From the outside, though, you treat the CL1 as a typical computer. You can plug in USB devices, cameras, even actuators if you want your CL1 to control a physical system. (Which, frankly, human neurons are typically pretty good at.) And there's a touchscreen so you can see system status or view live data. Five years ago, Cortical Lab's then-CTO Andy Kitchen told me they were deploying systems with tens of thousands of neurons to hundreds of thousands of neurons, but that their roadmap included 'scaling that up to millions of neurons." Now Cortical Labs sees their biological computers growing to hundreds of millions of cells, and with different technologies, billion or trillion-cell levels. However, there's not a direct one-to-one equivalent with neuromorphic neurons in a silicon-based system, he added. Biological neurons are much more powerful, he says. Interestingly, communicating with physical human neurons in a biological computer is vastly different than writing computer code to an artificial computer. 'The premier way would be to describe your task somehow, probably through some sort of very high-level language, and then we would turn that into a stimulus sequence which would shape biological behavior to fit your specification,' Kitchen told me. Part of the difference is how to encode and communicate the problem, and part of the difference is that the CL1 neurons, like the ones in your brain right now, have some plasticity: they can essentially reprogram themselves for different tasks. Essentially, the neurons learn how to solve your problem, just like you learn how to do new things. You won't likely see CL1 systems in general use anytime soon: currently, the targeted customers are in medical fields like drug discovery and disease modeling, says IEEE Spectrum. There's the added value that scientists can perform experiments on a little synthetic brain as well. If all of this seems on the edge of creepy, or even right over, that's likely because it is. CL1 says they don't do any animal testing, although they did start with mouse neurons, and they say that the human brain cells in their biological computers are lab-grown. But clearly the first human neurons came from somewhere. Cortical Labs says customers have to get 'ethical approval' to general cell lines, and require buyers to have proper facilities to maintain the biological chips. What exactly that means, however, is unclear. Soon we may see physical system in the world, like humanoid robots, with partially organic components to their brains.

Why Trump has struggled to get Xi on the phone to talk trade
Why Trump has struggled to get Xi on the phone to talk trade

CNN

timean hour ago

  • CNN

Why Trump has struggled to get Xi on the phone to talk trade

For months, President Donald Trump has suggested his personal relationship with China's Xi Jinping will be what unlocks the world's most consequential trade dispute. Yet he couldn't get Xi on the telephone for weeks. The long period of silence between the leaders will — at least in the White House's telling — come to an end this week. A string of US officials have all but confirmed a call between Trump and Xi is imminent and could occur as early as Thursday, even though Beijing remains tight-lipped. 'I am afraid we don't have comments for you right now,' a spokesman for the Chinese embassy in Washington said in response to questions about the forthcoming conversation. The discrepancy in how each side was talking — or not talking — about the call ahead of time only underscored the widening gulf between the world's two largest economies. Each side seems convinced the call could fall through at any moment. And it's not only fights over tariffs, critical minerals, jet engine parts or computer chips that have caused a rift. It's also a matter of the two leaders' vastly different styles. While Trump is eager to apply his dealmaking tactics directly with Xi, his model of leader-to-leader haggling is entirely at odds with how Chinese officials approach global negotiations. Deeply wary of Trump's unpredictability and track record of putting foreign leaders in awkward or embarrassing situations, Chinese officials had put off a phone call, according to people familiar, even as Trump stated on multiple occasions this spring that he expected to speak with Xi soon. His Oval Office ambushes of Ukraine's Volodymyr Zelensky and South Africa's Cyril Ramaphosa caught the attention of officials in China, those people added, and officials wanted to avoid anything similar, even in a private conversation. Former Trump and Biden administration officials describe meetings and calls with Xi as heavily scripted. Little is left to chance, they said, and even the small items – like timing and translation – are heavily negotiated among staff ahead of time. When President Joe Biden met Xi outside San Francisco two years ago, details as minute as the type of flowers sitting on the table between the two men were subject to delicate and intense discussions between the two sides, officials said at the time. On phone calls with US presidents, Xi typically reads directly from prepared talking points that are often verbatim of what he's said in previous conversations, the former officials said. When Xi briefly put down his script to offer off-the-cuff reminiscences during his final meeting last year with Biden – a man he'd known for more than a decade – US officials regarded it as a major show of respect. The stilted format makes it nearly impossible to delve into specifics that haven't been agreed to ahead of time. Any actual negotiation on trade deals or joint statements often happens among staff weeks or months ahead of time. That is not how Trump prefers to operate. As his press secretary said this week, his is a 'top-down approach,' where policy discussions originate from the Resolute Desk. 'He's very much involved in literally every policy discussion and decision that takes place,' Karoline Leavitt said Tuesday when questioned about a reduction in the size of Trump's National Security Council. That has been especially true on China, according to officials. Trump regards securing a new agreement with Beijing both as a critical component of his broader trade agenda and as a necessary follow-up from his first term, when trade deals with China got derailed during the Covid-19 pandemic. Trump views his relationship with Xi through a personal lens, harkening back to their interactions during his first term. It only took 76 days after Trump's 2017 swearing-in for Xi to fly to Mar-a-Lago, where he was served a 'beautiful' piece of chocolate cake and serenaded in Mandarin by Trump's granddaughter. Xi has proven far more difficult to reach in Trump's second term – and he's shown no similar rush to pay a visit to Florida, frustrating the US president. The last time Trump is known to have spoken with Xi was on January 17, days ahead of his second inauguration. 'It is my expectation that we will solve many problems together, and starting immediately,' Trump said afterward. But the problem-solving did not start immediately. Instead, the relationship between the two countries quickly worsened after Trump applied stiff new tariffs that eventually rose to 145%. China retaliated, creating a tit-for-tat trade war that has expanded over the course of Trump's five months in office. Talks last month in Geneva, which were intended to alleviate tensions, at first appeared to yield some progress – both sides vowed to lower some of the tariffs. But weeks later, the US accused China of reneging on an agreement to ease restrictions of certain critical minerals used to produce magnets. And instead of improving, the trade war has expanded into a battle over supply chains, which both countries see as essential to their respective national security needs. Trump has expanded punitive measures toward China to include revoking visas for Chinese students studying at American universities and restricting the export of certain software used to design advanced semiconductors. The worsening tensions emphasized the need for the two leaders to speak directly. 'The trade teams on both sides have determined that this needed to be elevated to the top,' a senior White House official said of the impending call. Trump is expected to bring up the pace at which China is exporting critical minerals – he believes Beijing is intentionally moving slower than promised during the Geneva talks, that official said. Another official said they expected Trump to do some level-setting: Trump has said publicly that China will suffer from the lack of a trade deal, a belief held by many administration officials, which in their view gives them leverage in talks with the superpower. 'I'm confident that when President Trump and Party Chairman Xi have a call that this will be ironed out,' Treasury Secretary Scott Bessent said over the weekend. For his part, Trump seemed to be mulling the looming conversation in the wee hours this week. 'I like President XI of China, always have, and always will, but he is VERY TOUGH, AND EXTREMELY HARD TO MAKE A DEAL WITH!!!' Trump wrote on Truth Social at 2:17 a.m. on Wednesday.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store